AMPA reduces surface expression of NR1 through regulation of GSK3β

NeuroReport

Volumn 20, Issue 2, 2009, Pages 161-165

  Nishimoto, Takaaki ^a   Kihara, Takeshi ^a   Akaike, Akinori ^a   Niidome, Tetsuhiro ^a   Sugimoto, Hachiro ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

amino 3 hydroxy 5 methyl 4 isoxazole propionate; Glutamate; Glycogen synthase kinase 3 ; N methyl d aspartate; Neurotoxicity; NR1

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CALCIUM ION; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; RECEPTOR SUBUNIT; AMINO ACID RECEPTOR STIMULATING AGENT; CALCIUM; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR1 NMDA RECEPTOR;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BIOTINYLATION; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME INHIBITION; FETUS; HUNTINGTON CHOREA; NERVE CELL CULTURE; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; ANALYSIS OF VARIANCE; ANIMAL; BRAIN CORTEX; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; IMMUNOBLOTTING; METABOLISM; NERVE CELL;

ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANALYSIS OF VARIANCE; ANIMALS; BIOTINYLATION; CALCIUM; CEREBRAL CORTEX; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; GLYCOGEN SYNTHASE KINASE 3; IMMUNOBLOTTING; NEURONS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 59149093472     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNR.0b013e3283118450     Document Type: Article

References (24)

1. Michaelis EK. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 1998; 54:369-415.
2. Choi DW, Rothman SM. The role of glutamate neurotoxicity in hypoxic- ischemic neuronal death. Annu Rev Neurosci 1990; 13:171-182.
3. Fan M, Raymond L. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease. Prog Neurobiol 2007; 81:272-293.
4. Hynd M, Scott H, Dodd P. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 2004; 45:583-595.
5. Perez-Pinzon M, Xu G, Dietrich W, Rosenthal M, Sick T. Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J Cereb Blood Flow Metab 1997; 17:175-182.
6. Wu X, Zhu D, Jiang X, Okagaki R Mearow K, Zhu G, et al. AMPA protects cultured neurons against glutamate excitotoxicity through a phosphatidylinositol 3-kinase-dependent activation in extracellular signal- regulated kinase to upregulate BDNF gene expression. J Neurochem 2004; 90:807-818.
7. Nishimoto T, Kihara T, Akaike A, Niidome T, Sugimoto H. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3 beta. J Neurosci Res 2008; 86:1096-1105.
8. Takadera T, Ohyashik T. Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons. Eur J Pharmacol 2004; 499:239-245.
9. Song L, Sarno P, Jope R. Central role of glycogen synthase kinase-3β in endoplasmic reticulm stress-induced caspase-3 activation. J Biol Chem 2002; 277:44701-44708.
10. Grimes C, Jope R. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 2001; 65:391-426.
11. Chen P, Gu Z, Liu W, Yan Z. Glycogen Synthase Kinase 3 Regulates NMDA Receptor Channel Trafficking and Function in Cortical Neurons. Mol Pharmacol 2007; 72:40-51.
12. Nonaka S, Hough C, Chuang D. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci U S A 1998; 95:2642-2647.
13. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H et al. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 1997; 42:159-163.
14. Shirakawa H, Katsuki H, Kume T, Kaneko S, Ito J, Akaike A. Ragulation of N-methyl-D-aspartate cytotoxicity by neuroactive steroids in rat cortical neurons. Eur J Pharmacol 2002; 454:165-175.
15. Mattson M, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel R. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992; 12:376-389.
16. Hollmann M, Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 1994; 17:31-108.
17. Mcllhinney RA, Molnár E. Characterization, cell-surface expression and ligand-binding properties of different truncated N-terminal extracellular domains of the ionotropic glutamate receptor subunit GluR1. Biochem J 1996; 315:217-225.
18. Perez-Otano I, Schulteis CT, Contractor A, Upton SA, Trimmer JS, Sucher NJ et al. Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors. J Neurosci 2001; 21:1228-1237.
19. Lysko P, Cox J, Vigano M, Henneberry R. Excitatory amino acid neurotoxicity at the N-methyl-D-aspartate receptor in cultured neurons: pharmacological characterization. Brain Res 1989; 499:258-266.
20. Carroll R, Zukin R. NMDA-receptor trafficking and targeting: implications for synaptic transmission and plasticity. Trends Neurosci 2002; 25:571-577.
21. Ehlers M, Tingley W, Huganir R. Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. Science 1995; 269:1734-1737.
22. Korolchuk V, Banting G. Kinases in clathrin-mediated endocytosis. Biochem Soc Trans 2003; 31:857-860.
23. Takei K, Yoshida Y, Yamada H. Regulatory mechanisms of dynamin-dependent endocytosis. J Biochem 2005; 137:243-247.
24. Standley S, Roche K, McCallum J, Sans N, Wenthold R. PDZ domain suppression of an ER retention signal in NMDA receptor NR1 splice variants. Neuron 2000; 28:887-898.